Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

When Will the ATOM Bomb Launch?

Investment advisor Daniel Carlson makes his case for why investors should have no fear of losing out on this technology company. Atomera Inc. (ATOM:NASDAQ) is going to blow up. I mean this in a good way, not in the implosion sort of manner. ATOM is a tickin...

Novamind Selected by Merck to Advance Research for Treatment-Resistant Depression

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site Independent validation of the expertise and capabilities of Novamind in managing clinical trials Adds to established track record conducting research a...

Strategic growth, EBITDA success and new leadership: Ciscom's Q3 2023 update

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Today we are talking with Ciscom Corp. (CSE:CISC) , which is focused on technology-driven marketing and advertising and content management organizations. ...

Imagin Medical Poised for Breakout with Bladder Cancer Detection Device in FDA Approval Process

A new advancement in bladder-related endoscopic surgery is endorsed and de-risked. You don't often hear about it, but bladder cancer is the sixth most common cancer in the U.S., with approximately 80,000 cases reported every year, and some 600,000 Americans living in ...

Biopharma Reports Consistent 'Phase 2 Liver Fat (NASH and NAFLD) Results'

The new data are reviewed and updates are provided on Can-Fite BioPharma's other clinical studies, including one for COVID-19, in this Dawson James research report. In an April 20 research note, Dawson James analyst Jason Kolbert wrote that results from Can...

Resonant's Cup Is Half-Empty. . .Or, Is It Half-Full?

You gotta love Resonant Inc. (RESN:NASDAQ) . It seems like every quarter the company misses earning projections, yet dangles a carrot so delicious that investors get distracted. Shorts have reason to feel good; so do the bulls. RESN is a great battleground stock where ...

Delta 9 CEO on Achieving Further Profits and Success in Cannabis

(Image via Delta 9 Cannabis) If you ask many cannabis operators how to achieve success in today’s market, you’d find it hard to get a confident reply. Yet Delta 9 Cannabis Inc. ( TSX:DN , OTC:VRNDF , Forum ) has been o...

Buzz on the Bullboards: TSX spotlight – Bombardier, Sonoro, PyroGenesis

As the markets on Bay Street and Wall Street show mixed signals, tech stocks are rallying and energy shares are lagging, the TSX is still capturing attention with its activity in various sectors. This week, three publicly listed companies have been generating significan...

Better & Cheaper than the Competition: A Deeper Look at a Revolutionary EV Charging Platform

(Image courtesy of IONiX Pro Battery Technologies Inc.) From new tech, apps, and delivering its products to customers, 2021 has been a busy year for Extreme Vehicle Battery Technologies Corp. ( CSE: ACDC , Forum ) and its new, cutting-edge battery storag...

Bioasis Engages With the FDA: Here's What It Means

Last week Bioasis Technologies Inc. (BTI:TSX.V) heard back from the FDA on written questions they had submitted. These questions concern their lead investigational candidate xB3-001 and its development path. The company's goal, of course, is to bring this therapeutic in...
1 2 3 4 5 6 7 8 9 10 ...